Ohnuma; Kei
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ohnuma; Kei.The latest application filed is for "anti-human cd26 monoclonal antibody or antigen-binding fragment thereof".
- Ohnuma; Kei - Shinagawa-ku JP
- Ohnuma; Kei - Tokyo N/A JP
| Patent | Date |
|---|---|
| Anti-human CD26 monoclonal antibody or antigen-binding fragment thereof Grant 9,920,135 - Morimoto , et al. March 20, 2 | 2018-03-20 |
| Anti-human Cd26 Monoclonal Antibody Or Antigen-binding Fragment Thereof App 20160159925 - MORIMOTO; Chikao ; et al. | 2016-06-09 |
| Method of treating malignant mesothelioma Grant 8,771,688 - Morimoto , et al. July 8, 2 | 2014-07-08 |
| Method of treating malignant mesothelioma App 20140004103 - Morimoto; Chikao ; et al. | 2014-01-02 |
| Method Of Treating Malignant Mesothelioma App 20100135993 - Morimoto; Chikao ; et al. | 2010-06-03 |
| Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof Grant 7,704,686 - Morimoto , et al. April 27, 2 | 2010-04-27 |
| Methods of Identifying Immunoregulatory Agents, Immunoregulatory Agents, and Uses Thereof App 20070259824 - Morimoto; Chikao ; et al. | 2007-11-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 